科学・技術 · 業界パイプライン速報
Cardiomyocytes in Persistent Cancer Therapy Cardiac Dysfunction Show Contract and Natriuretic Peptide Signaling
BACKGROUND. Anthracycline and trastuzumab therapy of HER2-positive breast cancer causes cancer therapy-related cardiac dysfunction (CTRCD) in a subset of treated patients. OBJECTIVES. To determine the incidence of CTRCD.